Condensed Consolidated Interim Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
REVENUES:
Total revenues	$ 39,151	$ 29,045	$ 109,832	$ 79,847
COST OF REVENUES:
Total cost of revenues	11,974	8,095	33,804	21,681
Gross profit	27,177	20,950	76,028	58,166
OPERATING EXPENSES:
General and administrative	13,094	8,546	53,691	22,385
Sales and marketing	7,278	4,901	23,285	12,323
Technology and development	3,864	2,600	12,388	6,844
Total operating expenses	24,236	16,047	89,364	41,552
Income (loss) from operations	2,941	4,903	(13,336)	16,614
NON-OPERATING (EXPENSE) INCOME:
Interest expense	(4)	(1,485)	(11)	(4,287)
Other (expense) income	(52)	29	(48)	29
Total non-operating expense	(56)	(1,456)	(59)	(4,258)
Income (loss) before income taxes	2,885	3,447	(13,395)	12,356
Income taxes	287	154	656	704
Net income (loss)	2,598	3,293	(14,051)	11,652
Net income (loss) attributable to non-controlling interests	1,059		(5,903)
Net income (loss) attributable to Enfusion, Inc.	$ 1,539	3,293	$ (8,148)	11,652
Net income (loss) per Class A common shares attributable to Enfusion, Inc.:
Net income (loss) per Class A common shares attributable to Enfusion, Inc., Basic	$ 0.02		$ (0.11)
Net income (loss) per Class A common shares attributable to Enfusion, Inc., Diluted	$ 0.02		$ (0.11)
Weighted Average number of Class A common shares outstanding:
Weighted Average number of Class A common shares outstanding, Basic	85,156		84,508
Weighted Average number of Class A common shares outstanding, Diluted	131,760		84,508
Platform subscriptions
REVENUES:
Total revenues	$ 35,953	26,950	$ 101,064	73,697
COST OF REVENUES:
Total cost of revenues	10,077	6,878	28,453	18,539
Managed services
REVENUES:
Total revenues	2,504	1,877	7,130	5,140
COST OF REVENUES:
Total cost of revenues	1,776	1,125	5,059	2,968
Other
REVENUES:
Total revenues	694	218	1,638	1,010
COST OF REVENUES:
Total cost of revenues	$ 121	$ 92	$ 292	$ 174